Low sensitivity of rapid tests detecting anti-CoV-2 IgG and IgM in health care workers’ serum for COVID-19 screening
暂无分享,去创建一个
A. Marcello | M. Bovenzi | F. Ronchese | F. Rui | C. Negro | P. de Michieli | F. Larese Filon | A. Belgrano | M. Confalonieri | P. D’Agaro | F. Salton | L. Segat | M. Ruscio | P. Confalonieri | M. Poggianella | Antonio Purpuri | Davide Camata | Anna Belgrano
[1] S. Tonen-Wolyec,et al. Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests , 2021, Journal of Virological Methods.
[2] R. Rigolini,et al. Anti-SARS CoV2 antibody testing in healthcare workers: comparison between rapid-cassette tests, ELISA and CLIA methods. , 2021, Journal of biological regulators and homeostatic agents.
[3] L. Poon,et al. Neutralizing antibody titres in SARS-CoV-2 infections , 2021, Nature communications.
[4] C. Charpentier,et al. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott) , 2020, Journal of Clinical Virology.
[5] M. Bovenzi,et al. COVID-19 outbreak in healthcare workers in hospitals in Trieste, North-east Italy , 2020, Journal of Hospital Infection.
[6] G. Ippolito,et al. Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test , 2020, Journal of Clinical Virology.
[7] M. Peeters,et al. Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV , 2020, Journal of Clinical Virology.
[8] A. Kouatchet,et al. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech) , 2020, Journal of Clinical Virology.
[9] Steven Woloshin,et al. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications. , 2020, The New England journal of medicine.
[10] J. Koeleman,et al. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital , 2020, Clinical Microbiology and Infection.
[11] Ralph-Sydney Mboumba Bouassa,et al. Potential pitfalls of routine SARS‐CoV‐2 serology for mass screening , 2020, Journal of medical virology.
[12] Marie Tré-Hardy,et al. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody , 2020, Clinical chemistry and laboratory medicine.
[13] Akihide Ryo,et al. Interpreting Diagnostic Tests for SARS-CoV-2. , 2020, JAMA.
[14] X. Tang,et al. Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.
[15] A. Petherick. Developing antibody tests for SARS-CoV-2 , 2020, The Lancet.
[16] Å. Lundkvist,et al. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 , 2020, Infection ecology & epidemiology.
[17] Yuxin Chen,et al. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients , 2020, Emerging microbes & infections.
[18] D. Serraino,et al. COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis. , 2020, Epidemiologia e prevenzione.
[19] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.